OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

Altman and Musk were OpenAI’s founding co-chairs in 2015, but their relationship has devolved into name-calling and lawsuits.

Tensions between technology leaders Elon Musk and OpenAI CEO Sam Altman were on full display this week after the Tesla CEO ...

Elon Musk is clashing with OpenAI CEO Sam Altman over the Stargate artificial intelligence infrastructure project touted by ...

OpenAI CEO Sam Altman will brief U.S. officials on super-agents—AI systems set to revolutionize software development, finance ...

Sam Altman has told OpenAI fans to lower their expectations after rumors the company had achieved AGI went viral on X.

Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in ...

The Stargate project has big implications for U.S. AI leadership, but also for who's winning the new president's ear.

An icon in the shape of a lightning bolt. Impact Link Over the years, OpenAI CEO Sam Altman has shared predictions about where he thinks we're headed on artificial general intelligence ...

OpenAI has partnered with a new AI initiative led by a group co-founded with outgoing Special Presidential Envoy for Climate John Kerry that has pushed left-wing causes and has several board ...

Sam Altman has shut down online "hype" after rumors the company had achieved AGI behind closed doors went viral on X. OpenAI CEO Sam Altman is trying to calm the online hype surrounding his company.